Fortress Biotech Inc (FBIO) Stock Price, Quote & News

Company Profile

Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for inflammatory lesions of non-n...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 652 4500

Website: www.fortressbiotech.com

Address:

1111 Kane Concourse, Suite 301, Bay Harbor Islands, United States

ChaseDeluca Dec. 4 at 9:55 PM

$MBIO $FBIO $DERM $CKPT $F watch DEVS, todays news is massive! This can fly over night, SMX vibes. Tiny float, huge news, highly shorted. .............

0 · Reply

AverageTraders Dec. 4 at 8:55 PM

Micro float SNSE is getting a lot of attention! Could be the next crazy runner! Never chase those big runners that are up 100%+ .. Easy way to lose! Key is to buy early before the runs happen! 💎 These tiny float tickers are running 100-400% recently! SNSE starting to get discovered and trending on Stocktwits! Only 500k shares outstanding - keep it on watch bulls! $ABCL $FBIO $SNDX $TGTX breakout watch

1 · Reply

frontiere Dec. 4 at 8:14 PM

$MBIO Mustang Bio ref=$1.28 — NO pstn, but bullish — thanks for reading the filing @SMM82 , not many here do their homework. Great find re Fred Hutch patent renegotiation. 👍 on a +ve side: cash per share ~$2.3 right now w runway to 2028+ (as of 2025-09-30 cash=$19M w 7.3m sh outst and de minimis cash burn per Qtr due to de facto shell/zombie company). 👍Lindy chart - zoom out to 1-2 yrs out! 👍 Tho “old news” and Not recruiting, the 3 malignant glioma Ph1/1b trials — MB-101, MB-108 all Investigator-initiated — could well be recycled for more stock promotional PR, since the data can be analyzed. See July news https://rarecancernews.com/news/fda-names-mb-101-us-orphan-drug-certain-glioma-types/ Clin Trials MB-101 City of Hope https://clinicaltrials.gov/study/NCT02208362 MB-108 Uni Alabama https://clinicaltrials.gov/study/NCT03657576 MB-108 1b Alabama https://clinicaltrials.gov/study/NCT06614855 Cf $FBIO Fortress Bio the parent co 🤔

1 · Reply

FinSUN Dec. 4 at 4:18 PM

$CNVS crazy asymmetry .. even higher than $FBIO. don't be surprised if you find it at $5 in a session. It's just recalibration

0 · Reply

FinSUN Dec. 4 at 3:57 PM

$CNVS $FBIO My 2 loves

0 · Reply

FinSUN Dec. 4 at 3:45 PM

$FBIO

0 · Reply

LiquidThetaOptions Dec. 4 at 7:11 AM

💎 LiquidTheta® Live Actionable Trade Asset: $FBIO Contracts: $FBIO July 17, 2026 $5 Calls Scale in: $0.40- $0.49 Scale out: $1.57-$2.70 Profit Potential : 83% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

HedgeAlerts Dec. 4 at 6:43 AM

Hedge Alert Live - Protect Your Portfolio Contract: $FBIO $2.50 Put · DEC 19, 2025 Exp Entry Price: $0.20 - $0.20 Exit Price Target: $0.33 Profit Margin: +66% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

Waters59 Dec. 3 at 11:27 PM

$FBIO I bought yesterday at 2.73 and of course it went down to 2.47. You're welcome. lol

0 · Reply

FinSUN Dec. 3 at 9:49 PM

$FBIO love it

0 · Reply

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

FBIOP

Nov 12, 2025, 10:41 PM EST - 22 days ago

Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript

FBIOP

Nov 12, 2025, 4:01 PM EST - 22 days ago

Market Cap	79.77M
Revenue (ttm)	57.68M
Net Income (ttm)	-46.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-79.75%
Debt to Equity Ratio	0.73

Volume	589,000
Avg Vol	754,664
Day's Range	N/A - N/A
Shares Out	31.04M
Stochastic %K	55%
Beta	1.49
Analysts	Sell
Price Target	$10.75